These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28639493)

  • 1. Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritis.
    Eektimmerman F; Swen JJ; Böhringer S; Huizinga TW; Kooloos WM; Allaart CF; Guchelaar HJ
    Pharmacogenomics; 2017 Jul; 18(10):945-953. PubMed ID: 28639493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.
    Potter C; Cordell HJ; Barton A; Daly AK; Hyrich KL; Mann DA; Morgan AW; Wilson AG; ; Isaacs JD
    Ann Rheum Dis; 2010 Jul; 69(7):1315-20. PubMed ID: 20448286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis.
    Dávila-Fajardo CL; van der Straaten T; Baak-Pablo R; Medarde Caballero C; Cabeza Barrera J; Huizinga TW; Guchelaar HJ; Swen JJ
    Pharmacogenomics; 2015; 16(4):373-81. PubMed ID: 25823785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis.
    Aterido A; Cañete JD; Tornero J; Blanco F; Fernández-Gutierrez B; Pérez C; Alperi-López M; Olivè A; Corominas H; Martínez-Taboada V; González I; Fernández-Nebro A; Erra A; López-Lasanta M; López Corbeto M; Palau N; Marsal S; Julià A
    Front Immunol; 2019; 10():1459. PubMed ID: 31312201
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept.
    Ferreiro-Iglesias A; Montes A; Perez-Pampin E; Cañete JD; Raya E; Magro-Checa C; Vasilopoulos Y; Caliz R; Ferrer MA; Joven B; Carreira P; Balsa A; Pascual-Salcedo D; Blanco FJ; Moreno-Ramos MJ; Manrique-Arija S; Ordoñez MDC; Alegre-Sancho JJ; Narvaez J; Navarro-Sarabia F; Moreira V; Valor L; Garcia-Portales R; Marquez A; Gomez-Reino JJ; Martin J; Gonzalez A
    PLoS One; 2019; 14(2):e0213073. PubMed ID: 30818333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis.
    Julià A; Fernandez-Nebro A; Blanco F; Ortiz A; Cañete JD; Maymó J; Alperi-López M; Fernández-Gutierrez B; Olivè A; Corominas H; Erra A; Acosta-Colman I; Alonso A; López-Lasanta M; Tortosa R; Tornero J; Marsal S
    Pharmacogenomics J; 2016 Apr; 16(2):147-50. PubMed ID: 25896534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between PTPRC rs10919563 A/G and FCGR2A R131H polymorphisms and responsiveness to TNF blockers in rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC
    Rheumatol Int; 2016 Jun; 36(6):837-44. PubMed ID: 27074847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort.
    Plant D; Prajapati R; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
    Arthritis Rheum; 2012 Mar; 64(3):665-70. PubMed ID: 21952740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis.
    Sode J; Vogel U; Bank S; Andersen PS; Hetland ML; Locht H; Heegaard NH; Andersen V
    PLoS One; 2015; 10(10):e0139781. PubMed ID: 26440629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis.
    Márquez A; Ferreiro-Iglesias A; Dávila-Fajardo CL; Montes A; Pascual-Salcedo D; Perez-Pampin E; Moreno-Ramos MJ; García-Portales R; Navarro F; Moreira V; Magro C; Caliz R; Ferrer MA; Alegre-Sancho JJ; Joven B; Carreira P; Balsa A; Vasilopoulos Y; Sarafidou T; Cabeza-Barrera J; Narvaez J; Raya E; Cañete JD; Fernández-Nebro A; Ordóñez Mdel C; de la Serna AR; Magallares B; Gomez-Reino JJ; González A; Martín J
    Arthritis Res Ther; 2014 Mar; 16(2):R66. PubMed ID: 24612463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.
    Smolen JS; Burmester GR; Combe B; Curtis JR; Hall S; Haraoui B; van Vollenhoven R; Cioffi C; Ecoffet C; Gervitz L; Ionescu L; Peterson L; Fleischmann R
    Lancet; 2016 Dec; 388(10061):2763-2774. PubMed ID: 27863807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice.
    Bombardieri S; Ruiz AA; Fardellone P; Geusens P; McKenna F; Unnebrink K; Oezer U; Kary S; Kupper H; Burmester GR;
    Rheumatology (Oxford); 2007 Jul; 46(7):1191-9. PubMed ID: 17504821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohort.
    Smith SL; Plant D; Lee XH; Massey J; Hyrich K; Morgan AW; Wilson AG; Isaacs J; Barton A
    Pharmacogenomics; 2016 May; 17(7):715-20. PubMed ID: 27180831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.
    Einarsson JT; Geborek P; Saxne T; Kapetanovic MC
    J Rheumatol; 2015 May; 42(5):741-8. PubMed ID: 25684762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis.
    Krintel SB; Palermo G; Johansen JS; Germer S; Essioux L; Benayed R; Badi L; Ostergaard M; Hetland ML
    Pharmacogenet Genomics; 2012 Aug; 22(8):577-89. PubMed ID: 22569225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab in clinical practice. Outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure.
    Bennett AN; Peterson P; Zain A; Grumley J; Panayi G; Kirkham B
    Rheumatology (Oxford); 2005 Aug; 44(8):1026-31. PubMed ID: 15870150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial.
    Burmester GR; Mariette X; Montecucco C; Monteagudo-Sáez I; Malaise M; Tzioufas AG; Bijlsma JW; Unnebrink K; Kary S; Kupper H
    Ann Rheum Dis; 2007 Jun; 66(6):732-9. PubMed ID: 17329305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of an IRAK3 polymorphism as a genetic marker predicting response to anti-TNF treatment in rheumatoid arthritis.
    Sode J; Vogel U; Bank S; Andersen PS; Hetland ML; Locht H; Heegaard NHH; Andersen V
    Pharmacogenomics J; 2018 Jan; 18(1):81-86. PubMed ID: 27698401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritis.
    Cannon GW; DuVall SL; Haroldsen CL; Caplan L; Curtis JR; Michaud K; Mikuls TR; Reimold A; Collier DH; Harrison DJ; Joseph GJ; Sauer BC
    J Rheumatol; 2014 Oct; 41(10):1935-43. PubMed ID: 25128516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.